AbbVie & EvolveImmune Announce Cancer Biotherapeutics Collaboration
31 Oct 2024 //
GLOBENEWSWIRE
EvolveImmune Presents Pipeline Progress at SITC Annual Meeting
23 Oct 2024 //
GLOBENEWSWIRE
EvolveImmune Provides Program Update Highlighted by Closing of $37M Financing
13 Dec 2023 //
GLOBENEWSWIRE
Immunotherapy biotech raises $37M from backers like Pfizer, Takeda, BMS
13 Dec 2023 //
ENDPTS
EvolveImmune to Present Data Highlighting Costimulatory T Cell Engager Platform
18 Oct 2023 //
GLOBENEWSWIRE
EvolveImmune Enters into Collaboration with Kennedy Institute of Rheumatology
14 Jun 2023 //
GLOBENEWSWIRE
EvolveImmune Reports Preclinical Data Durable Anti-Tumor Efficacy with EV-104
10 Nov 2022 //
GLOBENEWSWIRE